Two Sigma Investments, LP Gilead Sciences, Inc. Put Options Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $330,888 - $375,564	-5,100 Reduced 2.72%	182,400 $13.2 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $3.99 Million - $4.3 Million	-58,900 Reduced 23.9%	187,500 $13.1 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $19 Million - $20.8 Million	-299,400 Reduced 54.86%	246,400 $17 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $16.7 Million - $19.1 Million	279,000 Added 104.57%	545,800 $35.3 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.62 Million - $1.85 Million	-28,600 Reduced 9.68%	266,800 $15.5 Million

Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $11.6 Million - $14.6 Million	186,800 Added 172.01%	295,400 $18.7 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $6.16 Million - $7.15 Million	85,100 Added 362.13%	108,600 $8.36 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $864,294 - $1.11 Million	-13,800 Reduced 37.0%	23,500 $1.76 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $11.6 Million - $12.7 Million	-187,900 Reduced 83.44%	37,300 $2.42 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $7.13 Million - $7.87 Million	114,000 Added 102.52%	225,200 $14.3 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $8.25 Million - $9.25 Million	-133,300 Reduced 54.52%	111,200 $7.51 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $11.8 Million - $13.2 Million	188,500 Added 336.61%	244,500 $15.9 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $2.8 Million - $3.65 Million	46,200 Added 471.43%	56,000 $3.5 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $14.8 Million - $16.4 Million	-207,200 Reduced 95.48%	9,800 $757,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $7.95 Million - $9.27 Million	122,500 Added 129.63%	217,000 $15.4 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $5.36 Million - $6.54 Million	73,600 Added 352.15%	94,500 $7.12 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $2.92 Million - $3.43 Million	-41,100 Reduced 66.29%	20,900 $1.5 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $4.47 Million - $5.3 Million	62,000	62,000 $5.02 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.41 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.87 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.8 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.2 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.96 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account